HomeAI · summaries
Storia in 19 fonti
FDA approves first-of-its-kind flu vaccine for adults over 50
Jump to contentThank you for registeringPlease refresh the page or navigate to another page on the site to be automatically logged inPlease refresh your browser to be logged inAllNewsSportCultureLifestyleThe U.S. Food and Drug Administration (FDA) approved Moderna's "mFLUSIVA," the first mRNA-based flu vaccine, for individuals over 50. This approval is a significant step towards modernizing flu vaccine development, enabling faster manufacturing to address various strains. Robert F. Kennedy Jr. previously withdrew $500 million in funding for mRNA vaccine development, claiming the vaccines were ineffective against Covid and flu, a stance contradicted by scientific studies. The FDA initially declined to review Moderna's application due to concerns about insufficient testing but later reversed its decision after Moderna submitted a revised application. The medical community criticized Kennedy's funding cut, warning of potential costs in both finances and lives, given that the flu continues to be a substantial public health concern. In fullFirst mRNA-based flu shot approved in US - despite RFK Jr’s objections to the scienceMore bulletinsThank you for registeringPlease refresh the page or navigate to another page on the site to be automatically logged inPlease refresh your browser to be logged in
Confronto fonti
6 prospettive sulla stessa storiaTimeline cronologica
- ·
healio.com
FDA approves first mRNA flu shot, mFlusiva
The FDA has approved the nation’s first messenger RNA-based influenza vaccine, marking a significant development in the fight against the respiratory illness — and the end of a…
- ·
forbes.com
FDA Approves First mRNA Flu Vaccine For Older Adults
The approval of Moderna’s new flu vaccine comes months after the FDA faced backlash for refusing to review the shot.
